Tags |
|
|
Links |
|
|
Advice Pool - How To Make A Relationship Last
For a relationship to last, there are few basic requirements. The rapidity
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
with which relationships are breaking in the modern days is a matter of c
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
oncern and we should try to find out how to make a relationship that lasts
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
for a long time. The major factors that affect the survival of a relation
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
hip are as below -
Selection Of Partner - Sometimes, our selection of par
Selection Of Partner - Sometimes, our selection of par
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
tner may be wrong. We may have nothing in common and our values and goals
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
may be very different. With bad selection from the beginning, no relations
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ip can survive for long. One of the main reasons of wrong partner selectio
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
n may be hurry in selection of partner and inattention to the true nature
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
of the selected partner.
Communication - bad communication is another rea
Communication - bad communication is another rea
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
on for break ups. Partners are unable to tell about true feelings to each
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
other for many reasons including fear of conflict. Sometimes, non-verbal c
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ommunication is made which fails in sending the message.
Expectations - H
Expectations - H
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
igh expectations in a relationship is another reason. We expect that after
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
we fall in to a relationship, we will become happy, satisfied and feel goo
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
d at all the times. That does not happen. This creates frustration and lea
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ds to blame on the relationship.
Sustaining relationships is difficult. I
Sustaining relationships is difficult. I
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
gives joy, but demand lot of efforts. Relationship is no solution to all
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
our life problems. Sometimes it creates its own problems. For a relationsh
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ip that lasts, we have to take care of all the aspects of the relationship
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/200869/advicepool-How-To-Make-A-Relationship-Last.html">How To Make A Relationship Last</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/200869/advicepool-How-To-Make-A-Relationship-Last.html]How To Make A Relationship Last[/url]
Related Articles:
Five Tips to Calm Cranky Customers
Bookmark it:
|